141 related articles for article (PubMed ID: 6432018)
1. The tolerability of a new oral controlled release theophylline preparation in patients with obstructive airways diseases.
Nolte D; Dusik B
Br J Clin Pract Suppl; 1984; 32():18-21. PubMed ID: 6432018
[No Abstract] [Full Text] [Related]
2. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
Grassi V; Nicora M; Beretta A
Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
[TBL] [Abstract][Full Text] [Related]
3. Clinical results obtained from a new controlled release theophylline preparation.
Nolte D
Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
[No Abstract] [Full Text] [Related]
4. [Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases].
Nolte D; Dusik B
Fortschr Med; 1983 Jul; 101(25):1203-6. PubMed ID: 6884955
[TBL] [Abstract][Full Text] [Related]
5. [Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline].
Gandola L; Aiolfi S; Soccini F; Patrini G; Capellini G; Scartabellati A; Ghio L; Mauri F
Clin Ter; 1989 Dec; 131(5):293-7. PubMed ID: 2532583
[TBL] [Abstract][Full Text] [Related]
6. [Long-term therapy with a retard theophylline preparation].
Keller A; Bömches B; Kandt D
Fortschr Med; 1995 May; 113(13):197-202. PubMed ID: 7782018
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
Kaik G
Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
[TBL] [Abstract][Full Text] [Related]
8. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
Baronti A; Verdiani P; Di Carlo S
Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
[No Abstract] [Full Text] [Related]
9. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].
Gatto PG; Bruzzoni A; Valenti V
Clin Ter; 1989 Jul; 130(1):45-9. PubMed ID: 2529079
[TBL] [Abstract][Full Text] [Related]
10. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
[No Abstract] [Full Text] [Related]
11. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
Harder S; Staib AH; Stauder J
Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931
[No Abstract] [Full Text] [Related]
12. [Comparison of two long-acting theophylline preparations in daily evening administration].
Holzer R
Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
[TBL] [Abstract][Full Text] [Related]
13. Slow release salbutamol and Tedral in the treatment of reversible airways obstruction.
Lal S; Bhalla KK; Davey AJ
Postgrad Med J; 1971 Mar; 47():Suppl:89-92. PubMed ID: 4929401
[No Abstract] [Full Text] [Related]
14. Slow release theophylline in patients with airways obstruction with particular reference to the effects of food upon serum levels.
Thompson PJ; Kemp MW; McAllister WA; Turner-Warwick M
Br J Dis Chest; 1983 Jul; 77(3):293-8. PubMed ID: 6351891
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of obstructive respiratory tract diseases. Study of afonilum retard in 3,512 patients].
Eichhorn J; Perré R
Med Welt; 1982 Dec; 33(50):1834-7. PubMed ID: 6762480
[No Abstract] [Full Text] [Related]
16. Combined administration of controlled release theophylline and ranitidine: a 53-day controlled survey in patients with chronic obstructive lung disease (COLD) and peptic disease.
Dal Negro R; Turco P; Pomari C; Trevisan F; De Conti F; Cordaro CI
Br J Clin Pract; 1987 Nov; 41(11):1004-8. PubMed ID: 3504314
[No Abstract] [Full Text] [Related]
17. The use of sustained-release theophylline ('Theo-dur') for the treatment of chronic reversible obstructive lung disease in hospital practice.
Riddington CJ; Shipman AJ
Br J Clin Pract; 1985 Apr; 39(4):148-53. PubMed ID: 3893504
[No Abstract] [Full Text] [Related]
18. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
Pollert I
Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
[No Abstract] [Full Text] [Related]
19. [Individual theophylline doses following ambulatory determination of theophylline clearance].
Harder S; Staib AH; Stauder J
Prax Klin Pneumol; 1986 Aug; 40(8):334-8. PubMed ID: 3748986
[No Abstract] [Full Text] [Related]
20. [Therapy of chronic obstructive respiratory syndrome with the new theophylline preparation Afonilum retard].
Dettmer HH
Fortschr Med; 1981 Jul; 99(25):1007-11. PubMed ID: 7262783
[No Abstract] [Full Text] [Related]
[Next] [New Search]
